With an increasing population and more prevalent staff shortages in healthcare, digital technologies can play a crucial role in bridging the gap to deliver value-based healthcare. Therefore, any additional service integrated into their workflow must either enhance efficiency in delivering care or add significant value to the care provided. Anything less would not align with their context of use and, consequently, would not effectively reach the end-user (patient).

As a market leader in joint arthroplasty, Zimmer Biomet introduced the mymobility care management platform. This platform offers remote patient monitoring, personalized care plans, telehealth services, and real-time data analytics to enhance patient engagement and streamline healthcare delivery. However, the adoption rate of this platform remains low, particularly when compared to the company's broader success in the implant market.

Through an analysis of quantitative patient outcome data and demographic data related to its use, it was found that one of the primary barriers to adoption was the low eagerness among healthcare professionals (HCPs) to use the care-management platform.

By leveraging the usage data currently collected by Zimmer Biomet and conducting qualitative inquiries, barriers to adoption were identified and opportunity areas were mapped. These insights led to the creation of a strategic roadmap designed to boost the adoption of the mymobility platform over the next five years.